In addition to IMT, receptor tyrosine kinase gene fusion has been reported in a variety of soft tissue neoplasms, such as S100/CD34-positive spindle cell mesenchymal neoplasm. This evidence concerns the gene NTRK1 and inflammatory myofibroblastic tumor.